SlideShare a Scribd company logo

When HER2 Is Low or Negative: Emerging Evidence on Antibody-Drug Conjugates for Hormone Receptor-Positive and Triple-Negative Breast Cancers

PeerVoice
PeerVoice

Aditya Bardia, MD, MPH, and Sara A. Hurvitz, MD, FACP, discuss breast cancer in this CE activity titled "When HER2 Is Low or Negative: Emerging Evidence on Antibody-Drug Conjugates for Hormone Receptor-Positive and Triple-Negative Breast Cancers." For the full presentation, please visit us at www.peervoice.com/XRM870.

When HER2 Is Low or Negative: Emerging Evidence on Antibody-Drug Conjugates for Hormone Receptor-Positive and Triple-Negative Breast Cancers

1 of 35
Download to read offline
When HER2 Is Low or Negative: Emerging Evidence on Antibody-Drug Conjugates for Hormone Receptor-Positive and Triple-Negative Breast Cancers
When HER2 Is Low or Negative: Emerging Evidence on Antibody-Drug Conjugates for Hormone Receptor-Positive and Triple-Negative Breast Cancers
When HER2 Is Low or Negative: Emerging Evidence on Antibody-Drug Conjugates for Hormone Receptor-Positive and Triple-Negative Breast Cancers
When HER2 Is Low or Negative: Emerging Evidence on Antibody-Drug Conjugates for Hormone Receptor-Positive and Triple-Negative Breast Cancers
When HER2 Is Low or Negative: Emerging Evidence on Antibody-Drug Conjugates for Hormone Receptor-Positive and Triple-Negative Breast Cancers
When HER2 Is Low or Negative: Emerging Evidence on Antibody-Drug Conjugates for Hormone Receptor-Positive and Triple-Negative Breast Cancers

Recommended

Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCExpert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCPeerVoice
 
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...PeerVoice
 
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...PeerVoice
 
Building a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical PracticesBuilding a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical PracticesPeerVoice
 
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...PeerVoice
 
Radioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPCRadioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPCPeerVoice
 
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...PeerVoice
 
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...PeerVoice
 

More Related Content

More from PeerVoice

Continuing Our Conversation in HCM: Compelling Questions and Evolving Conside...
Continuing Our Conversation in HCM: Compelling Questions and Evolving Conside...Continuing Our Conversation in HCM: Compelling Questions and Evolving Conside...
Continuing Our Conversation in HCM: Compelling Questions and Evolving Conside...PeerVoice
 
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023PeerVoice
 
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...PeerVoice
 
Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...
Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...
Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...PeerVoice
 
Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...
Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...
Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...PeerVoice
 
Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...
Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...
Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...PeerVoice
 
Key Updates on the Treatment Paradigm for Systemic Lupus Erythematosus
Key Updates on the Treatment Paradigm for Systemic Lupus ErythematosusKey Updates on the Treatment Paradigm for Systemic Lupus Erythematosus
Key Updates on the Treatment Paradigm for Systemic Lupus ErythematosusPeerVoice
 
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in R...
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in R...Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in R...
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in R...PeerVoice
 
Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-In...
Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-In...Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-In...
Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-In...PeerVoice
 
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...PeerVoice
 
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...PeerVoice
 
The Science and the Art of Modern Prostate Cancer Care: Improving Patient Out...
The Science and the Art of Modern Prostate Cancer Care: Improving Patient Out...The Science and the Art of Modern Prostate Cancer Care: Improving Patient Out...
The Science and the Art of Modern Prostate Cancer Care: Improving Patient Out...PeerVoice
 
Individualising ART as We Travel Through Time: Decisions Along a Life’s Journey
Individualising ART as We Travel Through Time: Decisions Along a Life’s JourneyIndividualising ART as We Travel Through Time: Decisions Along a Life’s Journey
Individualising ART as We Travel Through Time: Decisions Along a Life’s JourneyPeerVoice
 
Incorporating the Investigation of Itch Into the Patient Care Process for PBC...
Incorporating the Investigation of Itch Into the Patient Care Process for PBC...Incorporating the Investigation of Itch Into the Patient Care Process for PBC...
Incorporating the Investigation of Itch Into the Patient Care Process for PBC...PeerVoice
 
Providing State of the Art Care for People With Obesity: Can We Break Free Fr...
Providing State of the Art Care for People With Obesity: Can We Break Free Fr...Providing State of the Art Care for People With Obesity: Can We Break Free Fr...
Providing State of the Art Care for People With Obesity: Can We Break Free Fr...PeerVoice
 
When One Size Doesn’t Fit All: Optimising Molecular Testing and Personalising...
When One Size Doesn’t Fit All: Optimising Molecular Testing and Personalising...When One Size Doesn’t Fit All: Optimising Molecular Testing and Personalising...
When One Size Doesn’t Fit All: Optimising Molecular Testing and Personalising...PeerVoice
 
HIV and Hepatitis B: Managing Coinfections in PLWH
HIV and Hepatitis B: Managing Coinfections in PLWHHIV and Hepatitis B: Managing Coinfections in PLWH
HIV and Hepatitis B: Managing Coinfections in PLWHPeerVoice
 
Recognising the Rationale and Understanding the Outcomes for CTLA-4 Targeted ...
Recognising the Rationale and Understanding the Outcomes for CTLA-4 Targeted ...Recognising the Rationale and Understanding the Outcomes for CTLA-4 Targeted ...
Recognising the Rationale and Understanding the Outcomes for CTLA-4 Targeted ...PeerVoice
 
Catching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and Targeting
Catching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and TargetingCatching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and Targeting
Catching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and TargetingPeerVoice
 
Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now...
Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now...Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now...
Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now...PeerVoice
 

More from PeerVoice (20)

Continuing Our Conversation in HCM: Compelling Questions and Evolving Conside...
Continuing Our Conversation in HCM: Compelling Questions and Evolving Conside...Continuing Our Conversation in HCM: Compelling Questions and Evolving Conside...
Continuing Our Conversation in HCM: Compelling Questions and Evolving Conside...
 
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
 
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...
Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...
 
Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...
Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...
Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...
 
Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...
Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...
Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...
 
Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...
Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...
Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...
 
Key Updates on the Treatment Paradigm for Systemic Lupus Erythematosus
Key Updates on the Treatment Paradigm for Systemic Lupus ErythematosusKey Updates on the Treatment Paradigm for Systemic Lupus Erythematosus
Key Updates on the Treatment Paradigm for Systemic Lupus Erythematosus
 
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in R...
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in R...Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in R...
Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in R...
 
Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-In...
Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-In...Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-In...
Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-In...
 
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
 
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
 
The Science and the Art of Modern Prostate Cancer Care: Improving Patient Out...
The Science and the Art of Modern Prostate Cancer Care: Improving Patient Out...The Science and the Art of Modern Prostate Cancer Care: Improving Patient Out...
The Science and the Art of Modern Prostate Cancer Care: Improving Patient Out...
 
Individualising ART as We Travel Through Time: Decisions Along a Life’s Journey
Individualising ART as We Travel Through Time: Decisions Along a Life’s JourneyIndividualising ART as We Travel Through Time: Decisions Along a Life’s Journey
Individualising ART as We Travel Through Time: Decisions Along a Life’s Journey
 
Incorporating the Investigation of Itch Into the Patient Care Process for PBC...
Incorporating the Investigation of Itch Into the Patient Care Process for PBC...Incorporating the Investigation of Itch Into the Patient Care Process for PBC...
Incorporating the Investigation of Itch Into the Patient Care Process for PBC...
 
Providing State of the Art Care for People With Obesity: Can We Break Free Fr...
Providing State of the Art Care for People With Obesity: Can We Break Free Fr...Providing State of the Art Care for People With Obesity: Can We Break Free Fr...
Providing State of the Art Care for People With Obesity: Can We Break Free Fr...
 
When One Size Doesn’t Fit All: Optimising Molecular Testing and Personalising...
When One Size Doesn’t Fit All: Optimising Molecular Testing and Personalising...When One Size Doesn’t Fit All: Optimising Molecular Testing and Personalising...
When One Size Doesn’t Fit All: Optimising Molecular Testing and Personalising...
 
HIV and Hepatitis B: Managing Coinfections in PLWH
HIV and Hepatitis B: Managing Coinfections in PLWHHIV and Hepatitis B: Managing Coinfections in PLWH
HIV and Hepatitis B: Managing Coinfections in PLWH
 
Recognising the Rationale and Understanding the Outcomes for CTLA-4 Targeted ...
Recognising the Rationale and Understanding the Outcomes for CTLA-4 Targeted ...Recognising the Rationale and Understanding the Outcomes for CTLA-4 Targeted ...
Recognising the Rationale and Understanding the Outcomes for CTLA-4 Targeted ...
 
Catching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and Targeting
Catching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and TargetingCatching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and Targeting
Catching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and Targeting
 
Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now...
Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now...Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now...
Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now...
 

Recently uploaded

Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...
Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...
Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...Subrata Roy
 
SEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdf
SEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdfSEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdf
SEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdfmarlonduqueupb
 
ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.
ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.
ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.Divya Kanojiya
 
CERVICAL NECROTIZING FASCIITIS BY VINCENT MUBANGA.pptx
CERVICAL NECROTIZING FASCIITIS BY VINCENT MUBANGA.pptxCERVICAL NECROTIZING FASCIITIS BY VINCENT MUBANGA.pptx
CERVICAL NECROTIZING FASCIITIS BY VINCENT MUBANGA.pptxvincentmubanga
 
Epidemiological Study Design, Research Design, Clinical Research
Epidemiological Study Design, Research Design, Clinical ResearchEpidemiological Study Design, Research Design, Clinical Research
Epidemiological Study Design, Research Design, Clinical ResearchDr KHALID B.M
 
CHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
CHRONIC IMMUNE-MEDIATED Demyelinating NeuropathiesCHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
CHRONIC IMMUNE-MEDIATED Demyelinating NeuropathiesMohamed AbdElhady
 
how to look more attractive? | Boys Edition
how to look more attractive? | Boys Editionhow to look more attractive? | Boys Edition
how to look more attractive? | Boys Editionalibieb33d
 
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptxGLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptxWINCY THIRUMURUGAN
 
Approach to maternal collapse and cardiac arrest.pptx
Approach to maternal collapse and cardiac arrest.pptxApproach to maternal collapse and cardiac arrest.pptx
Approach to maternal collapse and cardiac arrest.pptxKTD Priyadarshani
 
seminario bio mol- sofia lopez valenciaa
seminario bio mol- sofia lopez valenciaaseminario bio mol- sofia lopez valenciaa
seminario bio mol- sofia lopez valenciaasofialopezvalencia
 
Seminario biología molecular Kevin Duque
Seminario biología molecular Kevin DuqueSeminario biología molecular Kevin Duque
Seminario biología molecular Kevin Duquekevinestebanduque
 
HEPATIKA 6 Nutritional supplement, six ingredients supported by clinical studies
HEPATIKA 6 Nutritional supplement, six ingredients supported by clinical studiesHEPATIKA 6 Nutritional supplement, six ingredients supported by clinical studies
HEPATIKA 6 Nutritional supplement, six ingredients supported by clinical studiesRichard Clement
 
Cell cytoskeleton and molecular motors.pdf
Cell cytoskeleton and molecular motors.pdfCell cytoskeleton and molecular motors.pdf
Cell cytoskeleton and molecular motors.pdfMedicoseAcademics
 
Bursitis is inflammation or irritation of a bursa sac. Bursae are small fluid...
Bursitis is inflammation or irritation of a bursa sac. Bursae are small fluid...Bursitis is inflammation or irritation of a bursa sac. Bursae are small fluid...
Bursitis is inflammation or irritation of a bursa sac. Bursae are small fluid...leejalashrestha2
 
skin diseases shaffer................ppt
skin diseases shaffer................pptskin diseases shaffer................ppt
skin diseases shaffer................pptHimanshu Goyal
 
GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...
GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...
GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...Abhinav S
 
Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...
Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...
Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...Abhinav S
 
Artificial Radionuclide Generators in Medicine Applications in Radiotherapy.pptx
Artificial Radionuclide Generators in Medicine Applications in Radiotherapy.pptxArtificial Radionuclide Generators in Medicine Applications in Radiotherapy.pptx
Artificial Radionuclide Generators in Medicine Applications in Radiotherapy.pptxDr. Dheeraj Kumar
 
Introducing amazing Healthy habits and fitness
Introducing amazing Healthy habits and fitnessIntroducing amazing Healthy habits and fitness
Introducing amazing Healthy habits and fitnessFredrick Amos
 

Recently uploaded (20)

Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...
Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...
Work-role of Radiation Therapists in the Consequences of Adaptive Radiotherap...
 
SEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdf
SEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdfSEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdf
SEMINARIO VIH BIOLOGIA MOLECULAR PDF.pdf
 
ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.
ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.
ANTI-HYPERTENSIVE DRUG - RAUWOLFIA ROOT.
 
CERVICAL NECROTIZING FASCIITIS BY VINCENT MUBANGA.pptx
CERVICAL NECROTIZING FASCIITIS BY VINCENT MUBANGA.pptxCERVICAL NECROTIZING FASCIITIS BY VINCENT MUBANGA.pptx
CERVICAL NECROTIZING FASCIITIS BY VINCENT MUBANGA.pptx
 
Epidemiological Study Design, Research Design, Clinical Research
Epidemiological Study Design, Research Design, Clinical ResearchEpidemiological Study Design, Research Design, Clinical Research
Epidemiological Study Design, Research Design, Clinical Research
 
CHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
CHRONIC IMMUNE-MEDIATED Demyelinating NeuropathiesCHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
CHRONIC IMMUNE-MEDIATED Demyelinating Neuropathies
 
Anti-interferon-gamma autoantibody associated immunodeficiency
Anti-interferon-gamma autoantibody associated immunodeficiencyAnti-interferon-gamma autoantibody associated immunodeficiency
Anti-interferon-gamma autoantibody associated immunodeficiency
 
how to look more attractive? | Boys Edition
how to look more attractive? | Boys Editionhow to look more attractive? | Boys Edition
how to look more attractive? | Boys Edition
 
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptxGLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
GLANDS IN THE SKIN,FUNCTIONS AND ABNORMALITIES ..pptx
 
Approach to maternal collapse and cardiac arrest.pptx
Approach to maternal collapse and cardiac arrest.pptxApproach to maternal collapse and cardiac arrest.pptx
Approach to maternal collapse and cardiac arrest.pptx
 
seminario bio mol- sofia lopez valenciaa
seminario bio mol- sofia lopez valenciaaseminario bio mol- sofia lopez valenciaa
seminario bio mol- sofia lopez valenciaa
 
Seminario biología molecular Kevin Duque
Seminario biología molecular Kevin DuqueSeminario biología molecular Kevin Duque
Seminario biología molecular Kevin Duque
 
HEPATIKA 6 Nutritional supplement, six ingredients supported by clinical studies
HEPATIKA 6 Nutritional supplement, six ingredients supported by clinical studiesHEPATIKA 6 Nutritional supplement, six ingredients supported by clinical studies
HEPATIKA 6 Nutritional supplement, six ingredients supported by clinical studies
 
Cell cytoskeleton and molecular motors.pdf
Cell cytoskeleton and molecular motors.pdfCell cytoskeleton and molecular motors.pdf
Cell cytoskeleton and molecular motors.pdf
 
Bursitis is inflammation or irritation of a bursa sac. Bursae are small fluid...
Bursitis is inflammation or irritation of a bursa sac. Bursae are small fluid...Bursitis is inflammation or irritation of a bursa sac. Bursae are small fluid...
Bursitis is inflammation or irritation of a bursa sac. Bursae are small fluid...
 
skin diseases shaffer................ppt
skin diseases shaffer................pptskin diseases shaffer................ppt
skin diseases shaffer................ppt
 
GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...
GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...
GERIATRIC PHARMACOLOGY Geriatric pharmacology is a specialized field focusing...
 
Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...
Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...
Circulatory shock Cardiogenic Shock Hypovolemic Shock Sepsis, Septic Shock an...
 
Artificial Radionuclide Generators in Medicine Applications in Radiotherapy.pptx
Artificial Radionuclide Generators in Medicine Applications in Radiotherapy.pptxArtificial Radionuclide Generators in Medicine Applications in Radiotherapy.pptx
Artificial Radionuclide Generators in Medicine Applications in Radiotherapy.pptx
 
Introducing amazing Healthy habits and fitness
Introducing amazing Healthy habits and fitnessIntroducing amazing Healthy habits and fitness
Introducing amazing Healthy habits and fitness